222 related articles for article (PubMed ID: 7540552)
1. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.
Benzing WC; Mufson EJ
Exp Neurol; 1995 Apr; 132(2):162-71. PubMed ID: 7540552
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
[TBL] [Abstract][Full Text] [Related]
4. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
5. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
Su JH; Cummings BJ; Cotman CW
Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
[TBL] [Abstract][Full Text] [Related]
6. Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease.
Uboga NV; Price JL
Neurobiol Aging; 2000; 21(1):1-10. PubMed ID: 10794842
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
Kondratick CM; Vandré DD
J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
[TBL] [Abstract][Full Text] [Related]
8. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
Richey PL; Siedlak SL; Smith MA; Perry G
Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621
[TBL] [Abstract][Full Text] [Related]
11. Association of APOE with tau-tangle pathology with and without β-amyloid.
Farfel JM; Yu L; De Jager PL; Schneider JA; Bennett DA
Neurobiol Aging; 2016 Jan; 37():19-25. PubMed ID: 26481403
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
14. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease.
Salehi A; Gonzalez Martinez V; Swaab DF
Neurobiol Aging; 1998; 19(6):505-10. PubMed ID: 10192208
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
[TBL] [Abstract][Full Text] [Related]
16. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
Shin RW
Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
Gómez-Ramos P; Mufson EJ; Morán MA
Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
[TBL] [Abstract][Full Text] [Related]
18. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962
[TBL] [Abstract][Full Text] [Related]
19. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary pathology and aluminum in Alzheimer's disease.
Shin RW; Lee VM; Trojanowski JQ
Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
